PDCD1 and small cell lung carcinoma: AC133 CAR-T has also been tested in metastatic SCLC models in conjunction with PD-1 inhibition and CD73 inhibition in an orthotopic xenograft mouse model with complete response seen in 25% of mice without evidence of GVHD [101].